- 随着新型冠状病毒（SARS-CoV-2）在世界范围内的传播，迫切需要更好地了解该病毒的致病机理并开发有效的抗病毒药物和疫苗。为了促进新型冠状病毒相关研究成果的传播与交流，并对未来世界范围内类似病毒性疾病的诊断和治疗带来启发，《中国病毒学（英）》Virologica Sinica今年开辟了新型冠状病毒主题专刊，并陆续发表了SARS-CoV-2主题的系列高质量论文，包括疫情初期的相关研究和报道（在线论文请见）：
- Clinical Features and Treatment of 2019-nCov Pneumonia Patients in Wuhan: Report of A Couple Cases
(by Zhan Zhang et al., 07 February 2020) - Compensation of ACE2 Function for Possible Clinical Management of 2019-nCoV-Induced Acute Lung Injury
(by Yuntao Wu, 07 February 2020) - Old Weapon for New Enemy: Drug Repurposing for Treatment of Newly Emerging Viral Diseases
(by Deyin Guo, 11 February 2020) - The First Disease X is Caused by a Highly Transmissible Acute Respiratory Syndrome Coronavirus
(by Shibo Jiang & Zheng-Li Shi, 14 February 2020) - Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools
(by Yajing Fu & Yuntao Wu et al., 03 March 2020) - A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility
(by Xing-Yi Ge et al., 20 March 2020) - Inefficiency of Sera from Mice Treated with Pseudotyped SARS-CoV to Neutralize 2019-nCoV Infection
(by Shibo Jiang & Lu Lu et al., 31 March 2020) - Development of a Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2
(by Chiyu Zhang et al., 01 April 2020) - The Rapid Assessment and Early Warning Models for COVID-19
(by Jing Li et al., 01 April 2020) - Computational Identification of Small Interfering RNA Targets in SARS-CoV-2
(by Wei Chen & Hao Lin et al., 15 April 2020) - Clinical Manifestation and Laboratory Characteristics of SARS-CoV-2 Infection in Pregnant Women
(by Wei Ren & Jianbo Xia et al., 20 April 2020) - A DNA Aptamer Based Method for Detection of SARS-CoV-2 Nucleocapsid Protein
(by Jianfeng Dai et al., 25 May 2020)
更多已投稿论文:
- Isolation and growth characteristics of SARS-CoV-2 in Vero cell
(by Hanping Zhu et al., Zhejiang Provincial CDC) - Conditionally reprogrammed cells: a physiological model for emerging viruses
(by Xuefeng Liu et al., Georgetown University Medical Center) - mRNA vaccines: possible tools to combat SARS-CoV-2
(by Junwei Li et al., Qingdao Agricultural University) - Conditionally reprogrammed human kidney proximal tubule epithelial cells maintain lineage function and express endogenous ACE2 and may serve as an ex vivo model for study of SARS-CoVs
(by Hui Li et al., Wuhan University) - Identification of SARS-CoV-2 with low viral load by deep sequencing from suspected COVID-19 Cases
(by Shuliang Chen et al., Wuhan University) - A study of two cases co-infected with SARS-CoV-2 and human immunodeficiency virus
(by Ke Lan et al., Wuhan University) - SARS-coronavirus-2 nsp13 possesses NTPase and RNA helicase activities that can be inhibited by bismuth salts
(by Xi Zhou et al., Wuhan Institute of Virology, CAS) - Severe Acute Respiratory Syndrome Coronavirus 2 does not replicate in Mosquito Aedes albopictus C6/36 Cells
(by Zhiming Yuan et al., Wuhan Institute of Virology, CAS) - Dynamic Changes of Antibody to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak
(by You Shang et al., Union Hospital, Huazhong University of Science and Technology) - Feasibility study of mixing throat swab samples for SARS-CoV-2 screening
(by Dingyu Zhang et al., Wuhan Jinyintan Hospital) - A systematic comprehensive review and validation of animal models for coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV
(by Bikash Medhi et al., Postgraduate Institute of Medical Education and Research) - COVID-19 outcomes in HIV/AIDS patients: a systematic review
(by Amer Harky et al., University of Liverpool) - Subclinical infection of SARS-CoV-2 in a close contact cohort in China
(by Jinlin Hou et al., Southern Medical University) - Discrimination of false negative results in RT-PCR detection of SARS-CoV-2 RNAs in clinical specimens by using an internal reference
(by Mengji Lu & Zhenhua Zhang et al., University of Duisburg-Essen; The Second Hospital of Anhui Medical University)
为了更快的分享新型冠状病毒相关的最新科学研究成果，我们对新冠主题的投稿施行“快速通道”政策。欢迎您的投稿！
文章类型包括研究论文（Research articles）、综述（Reviews）、短讯（Letters）和观点（Perspectives）。专刊所有论文，采用单篇在线优先出版模式并供全球学者免费阅读；论文发表后，即可收录进PubMed和WHO COVID-19专题库。
专刊编辑：石正丽 研究员（中科院武汉病毒研究所）
投稿链接: https://mc03.manuscriptcentral.com/vs
了解期刊更多信息:
www.virosin.org
https://www.springer.com/journal/12250
http://www.ncbi.nlm.nih.gov/pubmed?term=virologica%20sinica
https://www.ncbi.nlm.nih.gov/pmc/journals/3534
